TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Asker Healthcare Group AB ( (SE:ASKER) ) has shared an announcement.
Asker Healthcare Group AB reported a strong first quarter in 2025, with a 16% increase in net sales and a 17% rise in adjusted EBITA, driven by both organic growth and strategic acquisitions. The company’s recent listing on Nasdaq Stockholm and acquisitions in Ireland, the UK, and the Netherlands are expected to enhance its market position and support its goal of becoming a leading medtech provider in Europe.
The most recent analyst rating on (SE:ASKER) stock is a Buy with a SEK100.00 price target. To see the full list of analyst forecasts on Asker Healthcare Group AB stock, see the SE:ASKER Stock Forecast page.
More about Asker Healthcare Group AB
Asker Healthcare Group AB operates in the healthcare industry, focusing on providing medical products and solutions. The company is involved in strategic acquisitions to expand its market presence, particularly in Europe, and aims to be a leading player in the medtech market.
Average Trading Volume: 981,531
Current Market Cap: SEK34.16B
Learn more about ASKER stock on TipRanks’ Stock Analysis page.